Synthetic data, generated through artificial intelligence technologies such as generative adversarial networks and latent ...
In 2015, introduction of a disease staging system offered a framework for benchmarking progression to clinical type 1 ...
The COVID-19 pandemic reminded us of what vaccines can do to prevent life-threatening diseases.1 Respiratory infections such ...
The 2021 approval by regulatory agencies of belimumab, a B lymphocyte stimulator (BLyS) inhibitor, and the 2022 approval of anifrolumab, a type I interferon inhibitor, has increased the therapeutic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback